{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T04:12:18Z","timestamp":1793506338825,"version":"4.5.0"},"reference-count":37,"publisher":"Oxford University Press (OUP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,1,1]]},"DOI":"10.1309\/ajcpwex5yy4phscn","type":"journal-article","created":{"date-parts":[[2014,12,15]],"date-time":"2014-12-15T18:15:46Z","timestamp":1418667346000},"page":"105-119","source":"Crossref","is-referenced-by-count":16,"title":["Blast Phase in Chronic Myelogenous Leukemia Is Skewed Toward Unusual Blast Types in Patients Treated With Tyrosine Kinase Inhibitors"],"prefix":"10.1093","volume":"143","author":[{"given":"Yang","family":"Shi","sequence":"first","affiliation":[{"name":"Department of Pathology, Duke University Medical Center, Durham, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Rand","sequence":"additional","affiliation":[{"name":"Department of Pathology, Duke University Medical Center, Durham, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer H.","family":"Crow","sequence":"additional","affiliation":[{"name":"Department of Pathology, Duke University Medical Center, Durham, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph O.","family":"Moore","sequence":"additional","affiliation":[{"name":"Department of Medicine, Duke University Medical Center, Durham, NC."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anand S.","family":"Lagoo","sequence":"additional","affiliation":[{"name":"Department of Pathology, Duke University Medical Center, Durham, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2015,1,1]]},"reference":[{"key":"key\n\t\t\t\t20180602034126_b1-1430105","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0002-9343(93)90122-6","article-title":"Chronic myelogenous leukemia in the lymphoid blastic phase: characteristics, treatment response, and prognosis","volume":"94","author":"Derderian","year":"1993","journal-title":"Am J Med"},{"key":"key\n\t\t\t\t20180602034126_b2-1430105","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3109\/10428199509107903","article-title":"Immunophenotype and ultrastructural studies in blast crisis of chronic myeloid leukemia","volume":"19","author":"Nair","year":"1995","journal-title":"Leuk Lymphoma"},{"key":"key\n\t\t\t\t20180602034126_b3-1430105","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/306277a0","article-title":"Translocation of c-ab1 oncogene correlates with the presence of a Philadelphia chromosome in chronic myelocytic leukaemia","volume":"306","author":"Bartram","year":"1983","journal-title":"Nature"},{"key":"key\n\t\t\t\t20180602034126_b4-1430105","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/nrc2147","article-title":"Chronic myeloid leukaemia as a model of disease evolution in human cancer","volume":"7","author":"Melo","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"key\n\t\t\t\t20180602034126_b5-1430105","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1182\/blood-2006-02-005686","article-title":"Evolving concepts in the management of chronic myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet","volume":"108","author":"Baccarani","year":"2006","journal-title":"Blood"},{"key":"key\n\t\t\t\t20180602034126_b6-1430105","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1056\/NEJMoa062867","article-title":"Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia","volume":"355","author":"Druker","year":"2006","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180602034126_b7-1430105","volume-title":"Atlas of Tumor Pathology: Tumors of the Bone Marrow","author":"Brunning","year":"1994"},{"key":"key\n\t\t\t\t20180602034126_b8-1430105","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Jaffe","year":"2001","edition":"3rd ed"},{"key":"key\n\t\t\t\t20180602034126_b9-1430105","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Swerdlow","year":"2008","edition":"4th ed"},{"key":"key\n\t\t\t\t20180602034126_b10-1430105","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1182\/blood.V6.4.372.372","article-title":"Some speculations on the myeloproliferative syndromes","volume":"6","author":"Dameshek","year":"1951","journal-title":"Blood"},{"key":"key\n\t\t\t\t20180602034126_b11-1430105","first-page":"1211","article-title":"The immunophenotype of blast transformation of chronic myelogenous leukemia: a high frequency of mixed lineage phenotype in \u201clymphoid\u201d blasts and a comparison of morphologic, immunophenotypic, and molecular findings","volume":"11","author":"Khalidi","year":"1998","journal-title":"Mod Pathol"},{"key":"key\n\t\t\t\t20180602034126_b12-1430105","first-page":"181","article-title":"Blast crisis in chronic myeloid leukaemia","volume":"36","author":"Parikh","year":"1988","journal-title":"J Assoc Physicians India"},{"key":"key\n\t\t\t\t20180602034126_b13-1430105","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1056\/NEJMoa040258","article-title":"Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML","volume":"351","author":"Jamieson","year":"2004","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180602034126_b14-1430105","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1056\/NEJM198310063091404","article-title":"Lymphoid blast crises of chronic myelogenous leukemia represent stages in the development of B-cell precursors","volume":"309","author":"Bakhshi","year":"1983","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180602034126_b15-1430105","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/ajh.2830010414","article-title":"Evaluation of survival data for chronic myelocytic leukemia","volume":"1","author":"Sokal","year":"1976","journal-title":"Am J Hematol"},{"key":"key\n\t\t\t\t20180602034126_b16-1430105","first-page":"327","article-title":"Ph-positive chronic myeloid leukemia mimicking essential thrombocythemia and terminating into megakaryoblastic blast crisis: report of two cases with molecular studies","volume":"7","author":"Cervantes","year":"1993","journal-title":"Leukemia"},{"key":"key\n\t\t\t\t20180602034126_b17-1430105","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1046\/j.1365-2141.2002.03256.x","article-title":"A sequence of immuno-chemotherapy with rituximab, mobilization of in vivo purged stem cells, high-dose chemotherapy and autotransplant is an effective and non-toxic treatment for advanced follicular and mantle cell lymphoma","volume":"116","author":"Lazzarino","year":"2002","journal-title":"Br J Haematol"},{"key":"key\n\t\t\t\t20180602034126_b18-1430105","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1002\/ajh.20920","article-title":"Basophilic leukemia in recurrent chronic myelogenous leukemia blast phase","volume":"82","author":"Gill","year":"2007","journal-title":"Am J Hematol"},{"key":"key\n\t\t\t\t20180602034126_b19-1430105","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1097\/00007611-198010000-00008","article-title":"Basophilic transformation of chronic myelogenous leukemia","volume":"73","author":"Nissenblatt","year":"1980","journal-title":"South Med J"},{"key":"key\n\t\t\t\t20180602034126_b20-1430105","doi-asserted-by":"crossref","first-page":"e195","DOI":"10.1016\/j.leukres.2009.04.026","article-title":"Chronic myelogenous leukemia showing biphenotypic blast crisis followed by lineage switch to B lymphoblastic leukemia","volume":"33","author":"Oh","year":"2009","journal-title":"Leuk Res"},{"key":"key\n\t\t\t\t20180602034126_b21-1430105","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1182\/blood-2012-03-380147","article-title":"How I treat CML blast crisis","volume":"120","author":"Hehlmann","year":"2012","journal-title":"Blood"},{"key":"key\n\t\t\t\t20180602034126_b22-1430105","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1111\/j.1349-7006.2009.01154.x","article-title":"Breast cancer resistance protein\/ABCG2 is differentially regulated downstream of extracellular signal-regulated kinase","volume":"100","author":"Imai","year":"2009","journal-title":"Cancer Sci"},{"key":"key\n\t\t\t\t20180602034126_b23-1430105","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1182\/blood.V99.1.381","article-title":"Treatment of chronic myelogenous leukemia with the tyrosine kinase inhibitor STI571 results in marked regression of bone marrow fibrosis","volume":"99","author":"Beham-Schmid","year":"2002","journal-title":"Blood"},{"key":"key\n\t\t\t\t20180602034126_b24-1430105","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/jca.21306","article-title":"Acquired hemoglobin C secondary to transfusion with antigen-matched red blood cells","volume":"29","author":"Arps","year":"2014","journal-title":"J Clin Apher"},{"key":"key\n\t\t\t\t20180602034126_b25-1430105","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1084\/jem.183.3.811","article-title":"Tyrosyl phosphorylation and DNA binding activity of signal transducers and activators of transcription (STAT) proteins in hematopoietic cell lines transformed by Bcr\/Abl","volume":"183","author":"Carlesso","year":"1996","journal-title":"J Exp Med"},{"key":"key\n\t\t\t\t20180602034126_b26-1430105","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.1182\/blood-2010-12-322537","article-title":"BCR-ABL suppresses autophagy through ATF5-mediated regulation of mTOR transcription","volume":"118","author":"Sheng","year":"2011","journal-title":"Blood"},{"key":"key\n\t\t\t\t20180602034126_b27-1430105","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1182\/blood-2005-09-3732","article-title":"A MAPK\/HNRPK pathway controls BCR\/ABL oncogenic potential by regulating MYC mRNA translation","volume":"107","author":"Notari","year":"2006","journal-title":"Blood"},{"key":"key\n\t\t\t\t20180602034126_b28-1430105","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.1600-065X.2011.01090.x","article-title":"NF-kappaB subunit specificity in hemopoiesis","volume":"246","author":"Gerondakis","year":"2012","journal-title":"Immunol Rev"},{"key":"key\n\t\t\t\t20180602034126_b29-1430105","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.4049\/jimmunol.0802870","article-title":"IL-3 induces basophil expansion in vivo by directing granulocyte-monocyte progenitors to differentiate into basophil lineage-restricted progenitors in the bone marrow and by increasing the number of basophil\/mast cell progenitors in the spleen","volume":"182","author":"Ohmori","year":"2009","journal-title":"J Immunol"},{"key":"key\n\t\t\t\t20180602034126_b30-1430105","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1182\/blood-2011-01-328567","article-title":"Crosstalk between NOTCH and AKT signaling during murine megakaryocyte lineage specification","volume":"118","author":"Cornejo","year":"2011","journal-title":"Blood"},{"key":"key\n\t\t\t\t20180602034126_b31-1430105","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/leu.2010.298","article-title":"A deep-sequencing study of chronic myeloid leukemia patients in blast crisis (BC-CML) detects mutations in 76.9% of cases","volume":"25","author":"Grossmann","year":"2011","journal-title":"Leukemia"},{"key":"key\n\t\t\t\t20180602034126_b32-1430105","doi-asserted-by":"crossref","first-page":"3292","DOI":"10.1182\/blood-2009-03-212969","article-title":"The derivation of diagnostic markers of chronic myeloid leukemia progression from microarray data","volume":"114","author":"Oehler","year":"2009","journal-title":"Blood"},{"key":"key\n\t\t\t\t20180602034126_b33-1430105","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1182\/blood-2012-12-475194","article-title":"Monoclonal antibody targeting of IL-3 receptor alpha with CSL362 effectively depletes CML progenitor and stem cells","volume":"123","author":"Nievergall","year":"2014","journal-title":"Blood"},{"key":"key\n\t\t\t\t20180602034126_b34-1430105","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1136\/jcp.2006.042135","article-title":"CD56-positive haematological neoplasms of the skin: a multicentre study of the Cutaneous Lymphoma Project Group of the European Organisation for Research and Treatment of Cancer","volume":"60","author":"Assaf","year":"2007","journal-title":"J Clin Pathol"},{"key":"key\n\t\t\t\t20180602034126_b35-1430105","doi-asserted-by":"crossref","first-page":"4204","DOI":"10.1200\/JCO.2009.21.8230","article-title":"Impact of baseline BCR-ABL mutations on response to nilotinib in patients with chronic myeloid leukemia in chronic phase","volume":"27","author":"Hughes","year":"2009","journal-title":"J Clin Oncol"},{"key":"key\n\t\t\t\t20180602034126_b36-1430105","doi-asserted-by":"crossref","first-page":"4944","DOI":"10.1182\/blood-2009-04-214221","article-title":"Dasatinib treatment of chronic-phase chronic myeloid leukemia: analysis of responses according to preexisting BCR-ABL mutations","volume":"114","author":"Muller","year":"2009","journal-title":"Blood"},{"key":"key\n\t\t\t\t20180602034126_b37-1430105","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1182\/blood-2013-03-487728","article-title":"Unraveling the complexity of tyrosine kinase inhibitor-resistant populations by ultra-deep sequencing of the BCR-ABL kinase domain","volume":"122","author":"Soverini","year":"2013","journal-title":"Blood"}],"container-title":["American Journal of Clinical Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajcp\/article-pdf\/143\/1\/105\/24999294\/ajcpath143-0105.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,27]],"date-time":"2020-08-27T23:14:17Z","timestamp":1598570057000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajcp\/article\/143\/1\/105\/1761565"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,1]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2015,1,1]]},"published-print":{"date-parts":[[2015,1,1]]}},"URL":"https:\/\/doi.org\/10.1309\/ajcpwex5yy4phscn","relation":{},"ISSN":["1943-7722","0002-9173"],"issn-type":[{"value":"1943-7722","type":"electronic"},{"value":"0002-9173","type":"print"}],"subject":[],"published-other":{"date-parts":[[2015,1,1]]},"published":{"date-parts":[[2015,1,1]]}}}